Duchenne Muscular Dystrophy News and Research

RSS
Duchenne muscular dystrophy (DMD) is a progressive muscle disorder that causes the loss of both muscle function and independence. DMD is perhaps the most prevalent of the muscular dystrophies and is the most common lethal genetic disorder diagnosed during childhood today. Each year, approximately 20,000 children worldwide are born with DMD (one of every 3,500 male children).
New Gene Therapy Approach Improves Muscle Strength in DMD Mice

New Gene Therapy Approach Improves Muscle Strength in DMD Mice

Harnessing Enzymes for Making RNA Therapeutics

Harnessing Enzymes for Making RNA Therapeutics

Review: Role of Alternative Splicing Defects in Major Neurodegenerative Diseases

Review: Role of Alternative Splicing Defects in Major Neurodegenerative Diseases

Scarring on the Extracellular Matrix Causes Muscles to Stop Working in Duchenne Muscular Dystrophy

Scarring on the Extracellular Matrix Causes Muscles to Stop Working in Duchenne Muscular Dystrophy

The relationship between cancer and DMD gene expression discovered

The relationship between cancer and DMD gene expression discovered

Scientists receive $2.5 million NIH grant to define the role of lipid droplets in muscle stem cell function

Scientists receive $2.5 million NIH grant to define the role of lipid droplets in muscle stem cell function

Cell-derived therapy may help treat ventricular arrhythmia

Cell-derived therapy may help treat ventricular arrhythmia

Cellular therapy leads to meaningful functional improvements in DMD patients

Cellular therapy leads to meaningful functional improvements in DMD patients

Gene writing helps develop advanced therapies safely and effectively

Gene writing helps develop advanced therapies safely and effectively

New gene therapy could help treat Duchenne muscular dystrophy

New gene therapy could help treat Duchenne muscular dystrophy

Revolutionary CRISPR-based genome editing system treatment destroys cancer cells

Revolutionary CRISPR-based genome editing system treatment destroys cancer cells

Study shows CRISPR/Cas9 system can effectively treat metastatic cancers

Study shows CRISPR/Cas9 system can effectively treat metastatic cancers

Study finds utrophin-based therapy could be used to treat Duchenne muscular dystrophy

Study finds utrophin-based therapy could be used to treat Duchenne muscular dystrophy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.